---
actionable_items:
- action: hypothetically,
  category: investigation
  full_context: 'we could hypothetically, '
  priority: medium
companies:
- category: unknown
  confidence: medium
  context: Welcome everyone to the AI and Business Podcast. I'm Matthew D'Mello, editorial
    director here at
  name: Business Podcast
  position: 31
- category: unknown
  confidence: medium
  context: come everyone to the AI and Business Podcast. I'm Matthew D'Mello, editorial
    director here at Emerge AI Resea
  name: Matthew D
  position: 53
- category: unknown
  confidence: medium
  context: . I'm Matthew D'Mello, editorial director here at Emerge AI Research. Today's
    guest is Mary Flanagan, director of prod
  name: Emerge AI Research
  position: 97
- category: unknown
  confidence: medium
  context: ctor here at Emerge AI Research. Today's guest is Mary Flanagan, director
    of product management in digital projec
  name: Mary Flanagan
  position: 134
- category: unknown
  confidence: medium
  context: ecutive thought leaders, everyone from the CIO of Goldman Sachs to the
    head of AI at Raytheon and AI pioneers lik
  name: Goldman Sachs
  position: 1133
- category: unknown
  confidence: medium
  context: o the head of AI at Raytheon and AI pioneers like Yoshua Benjiro. With
    nearly a million annual listeners, AI and B
  name: Yoshua Benjiro
  position: 1198
- category: unknown
  confidence: medium
  context: eve you can help other leaders move the needle on AI ROI, visit emerge.com
    and fill out our thought leader
  name: AI ROI
  position: 1668
- category: tech
  confidence: high
  context: versation with Mary. This podcast is supported by Google. Hey everyone,
    David here, one of the product lea
  name: Google
  position: 2039
- category: unknown
  confidence: medium
  context: veryone, David here, one of the product leads for Google Gemini. If you
    dream it and describe it, VO3 and Gemini
  name: Google Gemini
  position: 2102
- category: unknown
  confidence: medium
  context: ackground noise, and even dialogue. Try it with a Google AI Pro plan or
    get the highest access with the Ultra pla
  name: Google AI Pro
  position: 2293
- category: unknown
  confidence: medium
  context: he product that I work with or support is IQVIA's Vigilance Detect. We
    have been using NLP, which is built on a prop
  name: Vigilance Detect
  position: 3800
- category: unknown
  confidence: medium
  context: mands from the insights that we're getting in AI. As I was saying, maybe
    before the microphones turned o
  name: As I
  position: 5459
- category: unknown
  confidence: medium
  context: nd that's how I see it at the moment. Absolutely. And I think there's also
    a lot of opportunities, whethe
  name: And I
  position: 10131
- category: unknown
  confidence: medium
  context: s committed to getting this right out of the box. And IQVIA in the area
    we're in, in healthcare-grade AI, our
  name: And IQVIA
  position: 10710
- category: unknown
  confidence: medium
  context: oys technology and digital channels for patients. So I think that by opening
    up additional patient chann
  name: So I
  position: 11948
- category: unknown
  confidence: medium
  context: hat sounds a lot like what we've seen in terms of Google Maps and traffic
    data and GPS data. Users giving feedb
  name: Google Maps
  position: 15695
- category: ai_media/research
  confidence: high
  context: The organization hosting the 'AI and Business Podcast' and featuring executive
    thought leaders on AI adoption.
  name: Emerge AI Research
  source: llm_enhanced
- category: ai_application/healthcare
  confidence: high
  context: The company where the guest works, heavily utilizing NLP, RPA, and OCR
    for drug safety, vigilance detection, and pharmacovigilance.
  name: IQVIA
  source: llm_enhanced
- category: enterprise_user/finance
  confidence: medium
  context: Mentioned as an organization whose CIO has been featured on the podcast,
    implying involvement in enterprise AI strategy.
  name: Goldman Sachs
  source: llm_enhanced
- category: enterprise_user/defense
  confidence: medium
  context: Mentioned as an organization whose head of AI has been featured on the
    podcast, implying involvement in enterprise AI strategy.
  name: Raytheon
  source: llm_enhanced
- category: ai_research/pioneer
  confidence: medium
  context: Mentioned as an AI pioneer featured on the show (likely a mispronunciation/reference
    to Yoshua Bengio).
  name: Yoshua Benjiro
  source: llm_enhanced
- category: big_tech
  confidence: high
  context: The podcast is supported by Google, and the subsequent segment features
    a product lead from Google Gemini.
  name: Google
  source: llm_enhanced
- category: big_tech/ai_product
  confidence: high
  context: A specific AI product/division within Google focused on generative video/multimodal
    AI.
  name: Google Gemini
  source: llm_enhanced
- category: regulatory_body
  confidence: high
  context: A regulatory body whose systems (like FAERS) are compared against real-time
    social media data analysis for drug safety signals.
  name: FDA (Food and Drug Administration)
  source: llm_enhanced
- category: regulatory_body
  confidence: high
  context: A regulatory body mentioned in the context of setting broad AI guidelines
    and standards.
  name: EMA (European Medicines Agency)
  source: llm_enhanced
- category: industry_collaboration
  confidence: high
  context: An industry working group laying out specifics for the pharmaceutical/safety
    industry, with which IQVIA collaborates.
  name: CMOSIX working group
  source: llm_enhanced
- category: ai_application/infrastructure
  confidence: medium
  context: Used as an analogy for how mass, quiet, user-generated data (like traffic/GPS)
    can solve existential problems, similar to social media data analysis in pharmacovigilance.
  name: Google Maps
  source: llm_enhanced
- category: regulatory_system/data
  confidence: high
  context: The FDA's adverse event reporting system, used as a benchmark against which
    social media detection is compared.
  name: FAERS system
  source: llm_enhanced
- category: enterprise_adopter_example
  confidence: high
  context: Mentioned as an example of an executive thought leader whose CIO is featured
    on the podcast regarding enterprise AI adoption.
  name: Goldman Sachs (CIO)
  source: llm_enhanced
- category: enterprise_adopter_example
  confidence: high
  context: Mentioned as an example of an executive thought leader whose Head of AI
    is featured on the podcast regarding enterprise AI adoption.
  name: Raytheon (Head of AI)
  source: llm_enhanced
- category: ai_research_pioneer
  confidence: high
  context: Mentioned as an AI pioneer featured on the show, indicating his status
    as a leading figure in AI research/development.
  name: Yoshua Bengio
  source: llm_enhanced
date: 2025-07-29 06:00:00 +0000
duration: 22
has_transcript: false
insights:
- actionable: false
  confidence: medium
  extracted: drug safety. She explains how natural language processing, or NLP, has
    been core to IQVIA's vigilance detection tools for over a decade, identifying
    safety signals upstream of traditional workflows. Throughout our conversation,
    Mary emphasizes the strategic pairing of NLP with automation tools like robotic
    process automation, or RPA, and optical character recognition, or OCR, to drastically
    improve adverse event detection outcomes in social media and other non-traditional
    data sources. But first, are you driving AI transformation at your organization,
    or maybe you're guiding critical decisions on AI investments, strategy, or deployment?
    If so, the AI and Business Podcast wants to hear from you. Each year, Emerge AI
    Research features hundreds of executive thought leaders, everyone from the CIO
    of Goldman Sachs to the head of AI at Raytheon and AI pioneers like Yoshua Benjiro.
    With nearly a million annual listeners, AI and Business
  text: the future of drug safety. She explains how natural language processing, or
    NLP, has been core to IQVIA's vigilance detection tools for over a decade, identifying
    safety signals upstream of traditional workflows. Throughout our conversation,
    Mary emphasizes the strategic pairing of NLP with automation tools like robotic
    process automation, or RPA, and optical character recognition, or OCR, to drastically
    improve adverse event detection outcomes in social media and other non-traditional
    data sources. But first, are you driving AI transformation at your organization,
    or maybe you're guiding critical decisions on AI investments, strategy, or deployment?
    If so, the AI and Business Podcast wants to hear from you. Each year, Emerge AI
    Research features hundreds of executive thought leaders, everyone from the CIO
    of Goldman Sachs to the head of AI at Raytheon and AI pioneers like Yoshua Benjiro.
    With nearly a million annual listeners, AI and Business is the go-to destination
    for enterprise leaders navigating real-world AI adoption.
  type: prediction
- actionable: false
  confidence: medium
  extracted: that? What are you seeing on the horizon just in terms of what the life
    sciences, what the healthcare landscape looks like once everybody's meeting patients
    where they are, no matter the format? Yeah, that's, I think the most exciting
    part of it, because up until maybe two years ago, the current social media as
    a source of patient information has been scoffed at. Essentially, there's been
    nothing meaningful coming out of social media, nothing meaningful that any safety
    scientist can do anything with, unfortunately. The regulators still require all
    of the various marketing authorization holders to review social media channels
    to make sure they're not missing anything, but it's been such a burden up until
    now, and there's been zero safety signals or events of consequence coming out
    of social media. And where we see that changing
  text: the future of that? What are you seeing on the horizon just in terms of what
    the life sciences, what the healthcare landscape looks like once everybody's meeting
    patients where they are, no matter the format? Yeah, that's, I think the most
    exciting part of it, because up until maybe two years ago, the current social
    media as a source of patient information has been scoffed at. Essentially, there's
    been nothing meaningful coming out of social media, nothing meaningful that any
    safety scientist can do anything with, unfortunately. The regulators still require
    all of the various marketing authorization holders to review social media channels
    to make sure they're not missing anything, but it's been such a burden up until
    now, and there's been zero safety signals or events of consequence coming out
    of social media. And where we see that changing is our ability to harness that
    information in a different way.
  type: prediction
layout: episode
llm_enhanced: true
original_url: https://traffic.libsyn.com/secure/techemergence/Business_-_7.29.25_-_Marie_Flanagan.mp3?dest-id=151434
processing_date: 2025-10-06 01:57:50 +0000
quotes:
- length: 107
  relevance_score: 5
  text: Outside of NLP, we also have these automation technologies that are not technically
    artificial intelligence
  topics: []
- length: 184
  relevance_score: 4
  text: She explains how natural language processing, or NLP, has been core to IQVIA's
    vigilance detection tools for over a decade, identifying safety signals upstream
    of traditional workflows
  topics: []
- length: 152
  relevance_score: 4
  text: But first, are you driving AI transformation at your organization, or maybe
    you're guiding critical decisions on AI investments, strategy, or deployment
  topics:
  - investment
- length: 128
  relevance_score: 4
  text: I think we're seeing natural language processing use cases across the board
    and that driving a lot of generative AI in the space
  topics: []
- length: 209
  relevance_score: 4
  text: At a very high level, and this is painting with a broad brush, I can already
    hear the Twitter trolls screaming about specifics, but NLP is kind of like the
    godfather, so to speak, of the LLMs that we see today
  topics: []
- length: 154
  relevance_score: 4
  text: A lot of what falls under NLP will get called large language models today,
    but that's kind of the overarching kind of data science discipline on top of it
  topics: []
- length: 145
  relevance_score: 4
  text: As we've the best metaphor I've heard it described, especially for RPA, is
    artificial intelligence is the brain and RPA is kind of like the hands
  topics: []
- length: 140
  relevance_score: 4
  text: Are you driving AI transformation at your organization or maybe you're guiding
    critical decisions on AI investments, strategy, or deployment
  topics:
  - investment
- impact_reason: Provides a crucial historical and conceptual link between traditional
    NLP and modern Large Language Models (LLMs), clarifying that LLMs are an evolution
    within the broader NLP discipline.
  relevance_score: 10
  source: llm_enhanced
  text: NLP is kind of like the godfather, so to speak, of the LLMs that we see today.
    It's the same discipline. A lot of what falls under NLP will get called large
    language models today, but that's kind of the overarching kind of data science
    discipline on top of it.
  topic: technical
- impact_reason: 'Strong business insight: pure AI/NLP is insufficient; success in
    complex domains requires a hybrid approach combining multiple automation technologies.'
  relevance_score: 10
  source: llm_enhanced
  text: I mean, this is a prime example of when if you just use AI or NLP in its purest
    AI form, we would not be able to narrow nearly as good results as we got when
    we combined a mix of automation technologies because the process of safety is
    unfortunately highly complicated.
  topic: business/strategy
- impact_reason: Quantifies the massive uplift (from 20-30% to 70-80% positive outcome)
    achieved by integrating RPA/OCR with NLP for unstructured data analysis in social
    media monitoring.
  relevance_score: 10
  source: llm_enhanced
  text: But once we apply OCR or RPA and various other automation techniques to take
    that data and move that data around in a way that is usable, we can get up to
    70, 80 percent positive outcome in searching social media for adverse events.
  topic: business/technical
- impact_reason: 'A powerful counter-narrative on automation: technology doesn''t
    just process data; it frees up human agents to focus on high-value, empathetic,
    and complex interactions.'
  relevance_score: 10
  source: llm_enhanced
  text: By putting technology there, you've done two things. You've enabled more information
    to come in, but you've also given the agents or the people interacting with patients
    more time in their day to exercise empathy, to have conversation, and to get more
    clinically robust information through...
  topic: strategy/human-in-the-loop
- impact_reason: 'Presents the ultimate goal: shifting pharmacovigilance from reactive
    reporting to proactive prevention, driven by real-world evidence gathered via
    digital channels.'
  relevance_score: 10
  source: llm_enhanced
  text: And that real-world evidence is something that the regulators are hungry for.
    It's something that's desperately needed for our industry and for this sort of
    point-of-care pharmacovigilance that we could hypothetically, and I say hypothetically,
    but it's coming around the corner, we could prevent adverse events happening rather
    than react to adverse events happening.
  topic: predictions/strategy
- impact_reason: Articulates a major strategic shift in pharmacovigilance and patient
    safety, moving from reactive response to proactive prevention using data/technology.
  relevance_score: 10
  source: llm_enhanced
  text: we could prevent adverse events happening rather than react to adverse events
    happening. Something we talk a lot about on that show, that difference between
    reactive and proactive workflows.
  topic: predictions
- impact_reason: A concrete example of AI/ML (pre-signaling/hotspotting) being used
    to detect emerging health trends significantly faster than traditional regulatory
    reporting systems.
  relevance_score: 10
  source: llm_enhanced
  text: We can now take that information and use it for some pre-signaling. So we've
    seen some really great examples how you can hotspot various incidences of influenza
    arising in certain suburbs in Manhattan, for example, and then correlate that
    data to what might exist in the FDA's FAERS system a couple of months later.
  topic: technical
- impact_reason: 'Crucial advice for AI adoption: success hinges on aligning technology
    implementation with existing, optimized workflows, not forcing technology onto
    broken processes.'
  relevance_score: 10
  source: llm_enhanced
  text: look at your workflow first. Look at the most practical steps you can take
    to implement digital enhancement in your workflow. Unfortunately, we've seen projects
    fail and AI projects fail because the workflow has not been conducive to it in
    successful.
  topic: business
- impact_reason: Defines a successful modern enterprise AI strategy as an integrated
    stack, combining various automation and ML techniques rather than relying on a
    single advanced AI solution.
  relevance_score: 10
  source: llm_enhanced
  text: Our best projects with the most favorable outcomes come from mixing RPA, OCR,
    traditional machine learning, and advanced AI. That's where the magic happens.
  topic: technical
- impact_reason: A profound insight into the future of regulatory compliance, shifting
    from punitive checks to verification of internal diligence and process integrity.
  relevance_score: 10
  source: llm_enhanced
  text: The regulators aren't checking you. They're checking that you're checking.
    That's where the cooperative environment is heading.
  topic: safety
- impact_reason: Strong summary of the regulatory paradigm shift towards process auditing
    over outcome auditing.
  relevance_score: 10
  source: llm_enhanced
  text: Here's another. The regulators aren't checking you. They're checking that
    you're checking. That's where the cooperative environment is heading.
  topic: safety
- impact_reason: Highlights the long-term, established use of NLP in a critical, highly
    regulated domain (drug safety), showing that advanced AI applications predate
    the current LLM hype cycle.
  relevance_score: 9
  source: llm_enhanced
  text: IQVIA has been in the AI game for a long, long time now, particularly NLP.
    So on the product that I work with or support is IQVIA's Vigilance Detect. We
    have been using NLP, which is built on a proprietary bank of safety trained keywords
    and patterns for the last 13, 14 years, to find safety events upstream of a traditional
    safety workflow.
  topic: technical/strategy
- impact_reason: Offers a necessary clarification on terminology, distinguishing between
    true AI (like OCR) and process automation (like RPA), which is important for accurate
    AI strategy discussions.
  relevance_score: 9
  source: llm_enhanced
  text: We also have these automation technologies that are not technically artificial
    intelligence... We of course focus on things like optical character recognition,
    which is AI, and robotic process automation, which is not technically AI.
  topic: technical/strategy
- impact_reason: Provides an excellent, accessible metaphor for understanding the
    relationship between cognitive AI (the brain) and execution automation (the hands/RPA).
  relevance_score: 9
  source: llm_enhanced
  text: As we've the best metaphor I've heard it described, especially for RPA, is
    artificial intelligence is the brain and RPA is kind of like the hands. It is
    kind of doing the work. It is following the commands from the insights that we're
    getting in AI.
  topic: strategy
- impact_reason: Emphasizes that 'artistry' in enterprise AI deployment lies in the
    strategic integration (mixing) of various technologies, not just adopting the
    newest model.
  relevance_score: 9
  source: llm_enhanced
  text: Our best projects with our most favorable outcomes have been because we have
    mixed RPA, OCR, traditional coding, traditional machine learning with more advanced
    AI techniques. When we see the magic happen, and that's the artistry of this,
    what we do in safety and particularly in finding safety adverse events in unstructured
    data.
  topic: strategy
- impact_reason: 'A crucial insight into the modern regulatory mindset: regulators
    are shifting from direct auditing to auditing the quality and robustness of the
    organization''s internal compliance checks (governance).'
  relevance_score: 9
  source: llm_enhanced
  text: The dynamic seems to be the regulators, the government, are there to check
    that you're doing the right thing, but they're kind of offloading the task of
    doing the due diligence. They're not checking. You're checking. They're checking
    that you're checking.
  topic: safety/regulation
- impact_reason: 'Explains the current regulatory approach to AI governance: broad
    principles are set, but the specific implementation details (granularity) are
    left to the industry to define and prove.'
  relevance_score: 9
  source: llm_enhanced
  text: They have not given us granularity in terms of what they expect because they
    will put that back on us. They have given us very, very broad set of specifics
    that they want to see and expect to see.
  topic: safety/regulation
- impact_reason: 'Actionable advice for regulated industries: leverage existing governance
    frameworks for AI, and note that regulators are deliberately avoiding overly prescriptive
    rules to prevent stifling innovation.'
  relevance_score: 9
  source: llm_enhanced
  text: So we're basing our AI governance model on existing risk management and data
    governance models that are there. But they're doing a pretty good job at keeping
    things broad enough that we do not inhibit our progress in implementing AI.
  topic: strategy/safety
- impact_reason: Draws a powerful analogy between public health surveillance using
    social media data and established successes in real-time traffic/logistics monitoring,
    validating the potential of mass data ingestion.
  relevance_score: 9
  source: llm_enhanced
  text: The other example I thought of in what you were talking about with social
    media being able to in terms of mass data be able to detect a virus, flu symptoms,
    moving through a population, that sounds a lot like what we've seen in terms of
    Google Maps and traffic data and GPS data.
  topic: technical
- impact_reason: Identifies the crucial shift from social media being a compliance
    burden to becoming an active, valuable data source for proactive decision-making.
  relevance_score: 9
  source: llm_enhanced
  text: And that kind of two-way movement of information is just become possible.
    That is something that is particularly exciting because social media up until
    now has been such a burden on companies.
  topic: strategy
- impact_reason: A balanced perspective warning against AI hype, emphasizing that
    simpler technologies like RPA can deliver significant, immediate workflow improvements.
  relevance_score: 9
  source: llm_enhanced
  text: AI is not the answer to everything either. There are other like your RPA,
    your oil in the engine. There are other minor changes that will have a big impact
    on your workflow.
  topic: business
- impact_reason: 'Actionable strategic advice: Start implementing digital transformation
    immediately, but mitigate risk by focusing on low-hanging fruit (shallow end use
    cases).'
  relevance_score: 9
  source: llm_enhanced
  text: You do want to jump in the pool right now. Make sure it's the shallow end
    and we could do a whole another episode on the best ways to really nail down use
    cases.
  topic: strategy
- impact_reason: A concise, powerful mandate for leaders to overcome inertia regarding
    digital transformation, stressing feasibility and immediacy.
  relevance_score: 9
  source: llm_enhanced
  text: Start small, but start. Don't let outdated workflows hold back technologies
    that are no longer cost prohibitive.
  topic: strategy
- impact_reason: Specific technical application showing predictive geographic health
    surveillance using unstructured data correlated with structured regulatory data.
  relevance_score: 9
  source: llm_enhanced
  text: We've seen some really great examples how you can hotspot various incidences
    of influenza arising in certain suburbs in Manhattan, for example, and then correlate
    that data to what might exist in the FDA's FAERS system a couple of months later.
  topic: technical
- impact_reason: Provides evidence that social media data is leading the curve on
    identifying emerging issues compared to official reporting channels.
  relevance_score: 9
  source: llm_enhanced
  text: And they're finding that actually we have seen this happening on social media
    and only months later when it's gone through its process, do we see it in the
    FDA system?
  topic: predictions
- impact_reason: Reinforces the necessity of a hybrid, multi-layered technology approach
    for achieving 'magic' results in enterprise transformation.
  relevance_score: 9
  source: llm_enhanced
  text: Here are a few we'd like to summarize for healthcare and life sciences leaders
    tuning into today's show. First, our best projects with the most favorable outcomes
    come from mixing RPA, OCR, traditional machine learning, and advanced AI. That's
    a direct quote from Mary.
  topic: technical
- impact_reason: 'A clear articulation of the value proposition for automation in
    highly regulated, high-volume data processing: replacing tedious human effort.'
  relevance_score: 8
  source: llm_enhanced
  text: What that represents is the use of technology instead of humans to do utterly
    tedious work and drive our collation effort into something that does not warrant
    it.
  topic: business/strategy
- impact_reason: Indicates a positive shift where regulatory bodies are actively encouraging,
    rather than just tolerating, digital transformation in safety monitoring.
  relevance_score: 8
  source: llm_enhanced
  text: What's really shifted in regulatory dynamics has been the encouragement of
    digitally enhancing your workflows for safety.
  topic: safety/regulation
- impact_reason: Illustrates the rapid evolution of data sourcing and regulatory acceptance
    regarding social media data in pharmacovigilance.
  relevance_score: 8
  source: llm_enhanced
  text: At one point in time, we were switching off comments on social media because
    we just didn't know how to deal with them. And now we have opened up channels
    for patients to report directly to regulators.
  topic: predictions/strategy
- impact_reason: Reinforces the concept of 'trustworthiness' as the core requirement
    for healthcare AI, demanding proactive guardrails built in collaboration with
    regulatory expectations.
  relevance_score: 8
  source: llm_enhanced
  text: IQVIA in the area we're in, in healthcare-grade AI, our trustworthiness of
    data is of paramount importance. And we are committed to putting up the necessary
    guardrails there in concert with what the regulators and safety industry would
    expect from us.
  topic: safety/business
- impact_reason: 'Identifies a key strategic shift: regulation is moving towards prioritizing
    patient experience and direct digital engagement.'
  relevance_score: 8
  source: llm_enhanced
  text: The changing regulatory environment in our industry is changing overall to
    be far more patient-centric in its approach to the way in which it deploys technology
    and digital channels for patients.
  topic: safety/strategy
- impact_reason: Provides context on the historical skepticism towards social media
    data in regulated industries like pharma, setting the stage for the subsequent
    technological breakthrough.
  relevance_score: 8
  source: llm_enhanced
  text: up until maybe two years ago, the current social media as a source of patient
    information has been scoffed at. Essentially, there's been nothing meaningful
    coming out of social media, nothing meaningful that any safety scientist can do
    anything with, unfortunately.
  topic: strategy
- impact_reason: Sets realistic expectations for the immediate impact of social media
    analytics—it informs strategy and signaling, rather than fundamentally altering
    drug safety profiles overnight.
  relevance_score: 8
  source: llm_enhanced
  text: So what we're seeing is the ability to maybe not use this information to change
    the safety profile of a drug. It won't hardly do that, but it will give you various
    information or analytics to help you determine what signaling activities you could
    do for your products in advance of the event becoming a problem.
  topic: business
- impact_reason: A bold claim about the speed advantage technology provides in public
    health monitoring compared to established bureaucratic systems.
  relevance_score: 8
  source: llm_enhanced
  text: We can detect these things faster than regulators.
  topic: predictions
- impact_reason: Identifies the primary bottleneck in enterprise AI adoption as use
    case definition, rather than regulatory hurdles or technology cost.
  relevance_score: 8
  source: llm_enhanced
  text: what we see people struggle with, not only regulatory challenges, they'll
    always be there, but finding the right use case.
  topic: business
- impact_reason: Challenges organizational complacency by asserting that the cost
    barrier for adopting efficiency-improving technology is now low.
  relevance_score: 8
  source: llm_enhanced
  text: You know, there is no reason that you can sit back and allow people to do
    activities that you know could well be served with technology. It's not that cost
    prohibitive.
  topic: business
- impact_reason: Reiterates the core theme of data-driven speed advantage in public
    health monitoring.
  relevance_score: 8
  source: llm_enhanced
  text: And we can detect these things faster than regulators. So very, very fascinating
    stuff.
  topic: predictions
- impact_reason: 'Summarizes the core shift in patient engagement strategy: ubiquity
    and channel agnosticism driven by digital tools.'
  relevance_score: 7
  source: llm_enhanced
  text: meeting patients where they are, no matter the format.
  topic: business
- impact_reason: Quantifies the historical lack of value derived from social media
    monitoring under old methods, justifying the need for new analytical approaches.
  relevance_score: 7
  source: llm_enhanced
  text: there's been zero safety signals or events of consequence coming out of social
    media.
  topic: technical
- impact_reason: 'Standard but essential business advice for technology investment:
    prioritize ROI when selecting digital enhancement projects.'
  relevance_score: 7
  source: llm_enhanced
  text: Look for where there is high-value returns for whatever it is that you're
    going to do.
  topic: business
- impact_reason: Actionable advice suggesting external expertise is valuable specifically
    for the strategic task of use case identification.
  relevance_score: 7
  source: llm_enhanced
  text: Make good use of consultants to find the right use cases for implementing
    technology.
  topic: business
source: Unknown Source
summary: '## Podcast Episode Summary: Enhancing Drug Safety with AI and Automation
  Technologies - with Marie Flanagan of IQVIA


  This 22-minute episode of the AI and Business Podcast, featuring **Marie Flanagan,
  Director of Product Management at IQVIA**, focuses on the critical role of AI and
  automation in transforming **drug safety and pharmacovigilance**. The discussion
  highlights how established AI disciplines, particularly Natural Language Processing
  (NLP), are being strategically combined with automation tools to improve adverse
  event (AE) detection, especially from unstructured and non-traditional data sources
  like social media.


  ---


  ### 1. Focus Area

  The primary focus is the application of **AI and automation technologies**—specifically
  **NLP, Robotic Process Automation (RPA), and Optical Character Recognition (OCR)**—to
  enhance **adverse event detection and safety signal monitoring** within the pharmaceutical
  industry. The conversation emphasizes moving from reactive to proactive safety workflows.


  ### 2. Key Technical Insights

  *   **Strategic Combination for Efficacy:** The most favorable outcomes in adverse
  event detection (e.g., achieving 70-80% positive outcomes from social media data)
  are achieved not by using pure AI alone, but by **mixing NLP/AI with automation
  tools like RPA and OCR** to process and structure complex, unstructured data.

  *   **NLP as the Foundation:** IQVIA has utilized proprietary, safety-trained NLP
  for over a decade (in their Vigilance Detect product) to find safety signals upstream
  of traditional workflows, noting that modern Large Language Models (LLMs) fall under
  the broader NLP discipline.

  *   **Automation as the "Hands":** RPA is described metaphorically as the "hands"
  that execute the commands derived from the "brain" (AI/NLP), emphasizing that while
  RPA is not strictly AI, it is essential "engine oil" for operationalizing AI insights
  in complex safety processes.


  ### 3. Business/Investment Angle

  *   **Social Media Maturation:** Social media, once dismissed as a source of meaningful
  safety data, is now becoming valuable for **pre-signaling**—detecting emerging health
  trends (like localized flu outbreaks) months before they appear in formal regulatory
  systems (like FAERS).

  *   **Regulatory Collaboration:** The dynamic between regulators (FDA, EMA) and
  industry is shifting toward **collaboration**. Regulators are encouraging digitalization
  and are primarily focused on verifying that companies have robust internal checking
  mechanisms ("They''re checking that you''re checking").

  *   **Workflow Optimization is Key:** Successful AI implementation hinges on first
  **analyzing and optimizing existing workflows**. Projects fail when the underlying
  process is not fit for digital enhancement.


  ### 4. Notable Companies/People

  *   **Marie Flanagan (IQVIA):** Guest and expert, providing insights from her role
  in product management for digital solutions, particularly IQVIA’s Vigilance Detect
  tool.

  *   **IQVIA:** The company whose long-standing use of NLP in pharmacovigilance serves
  as the central case study.

  *   **Regulators (FDA, EMA):** Mentioned as actively encouraging digital enhancement
  and setting broad, non-prescriptive guidelines for AI implementation.

  *   **C-M-O-S-I-X Working Group:** Mentioned as an influential industry body laying
  out specifics for the safety sector.


  ### 5. Future Implications

  The industry is moving toward a **patient-centric, proactive pharmacovigilance model**.
  By leveraging multi-channel data collection (including social media), automation
  frees up human agents to focus on empathy and gathering more clinically robust information,
  potentially allowing the industry to **prevent adverse events** rather than just
  react to them.


  ### 6. Target Audience

  This episode is highly valuable for **Life Sciences and Healthcare Executives, Product
  Managers, Regulatory Affairs Professionals, and Technology Leaders** involved in
  AI investment, strategy, and deployment within pharmaceutical and biotech companies.
  It is relevant for those navigating real-world AI adoption challenges.


  ---


  ### Comprehensive Narrative Summary


  The podcast episode provided a deep dive into how IQVIA leverages a sophisticated
  blend of AI and automation to modernize drug safety monitoring, moving beyond traditional,
  reactive workflows. Marie Flanagan established that **NLP has been a core component
  of IQVIA’s safety detection tools for over a decade**, sifting through vast, multilingual,
  unstructured datasets to identify adverse events upstream.


  A central theme was the **synergistic power of combining different technologies**.
  Flanagan stressed that while NLP is the "brain," automation tools like RPA (the
  "hands") and OCR are necessary to achieve high-fidelity results when processing
  complex data from sources like social media. Without this integration, NLP alone
  yields lower success rates (20-30%), whereas the combined approach boosts positive
  outcomes significantly (up to 70-80%).


  The discussion then pivoted to the **regulatory landscape**. Flanagan noted a positive
  shift where regulators are encouraging digitalization and adopting a more collaborative
  stance. The emphasis is now on industry self-governance; regulators are focused
  on auditing the *processes* companies use to ensure safety, rather than dictating
  granular technical specifications. This collaborative environment supports the move
  toward **Real-World Evidence (RWE)** gathering.


  Furthermore, the integration of technology is changing the role of the "human in
  the loop." By automating tedious data collation, agents gain time to exercise empathy
  and gather richer, more clinically robust information directly from patients via
  new digital channels. This enables the exciting future possibility of **proactive
  pharmacovigilance**—predicting and preventing safety issues before they escalate.
  Flanagan concluded with actionable advice for leaders: **"Start small, but start,"**
  prioritize workflow assessment before implementation, and seek high-value, tactical
  changes rather than waiting for perfect, large-scale AI solutions.'
tags:
- artificial-intelligence
- investment
- generative-ai
- google
title: Enhancing Drug Safety with AI and Automation Technologies - with Marie Flanagan
  of IQVIA
topics:
- keywords:
  - ai
  - machine learning
  - deep learning
  - neural networks
  - llm
  - large language model
  mentions: 63
  prominence: 1.0
  topic: artificial intelligence
- keywords:
  - investment
  - funding
  - valuation
  - ipo
  - acquisition
  mentions: 2
  prominence: 0.2
  topic: investment
- keywords:
  - generative ai
  - genai
  - chatgpt
  - gpt
  - claude
  - text generation
  - image generation
  mentions: 1
  prominence: 0.1
  topic: generative ai
---

<!-- Episode automatically generated from analysis data -->
<!-- Processing completed: 2025-10-06 01:57:50 UTC -->
